Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Carboplatin / administration & dosage
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Carcinoma, Non-Small-Cell Lung / mortality*
• Carcinoma, Non-Small-Cell Lung / pathology
• Chemotherapy, Adjuvant
• Disease-Free Survival
• Female
• Humans
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / mortality*
• Lung Neoplasms / pathology
• Male
• Neoplasm Staging
• Paclitaxel / administration & dosage
• Palliative Care
• Pneumonectomy
• Randomized Controlled Trials as Topic
• Risk Assessment
• Survival Analysis
• Tumor Burden / drug effects